Zenith Drugs Ltd (ZENH)

NSE

Currency in INR

Disclaimer

125.00

+1.35(+1.09%)

Real-time Data13:20:13

Fair Value

Day's Range

123.50

129.50

52 wk Range

52.80

154.40

ZENH Income Statement

Featured here, the Income Statement (earnings report) for Zenith Drugs Ltd, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2018

31/03

2019

31/03

2020

31/03

2021

31/03

2022

31/03

2023

31/03

2024

31/03

Total Revenues

1,145.19

1,316.2

Total Revenues Growth

+24.95%

+14.93%

Cost Of Revenues

853.26

855.07

Gross Profit

291.94

461.12

Gross Profit Growth

+54.11%

+57.95%

Gross Profit Margin %

25.49%

35.03%

Other Operating Expenses, Total

208.25

305.01

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+54.96%	+46.46%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	49.89	60.86
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	145.33	231.12

Operating Income

83.69

156.12

Operating Income Growth

+52.02%

+86.55%

EBIT Margin %

7.31%

11.86%

Net Interest Expenses

-18.11

-29.97

Net Interest Expenses Growth

-39.75%

-65.51%

Interest Expense, Total

-19.71

-29.97

Interest And Investment Income

1.6

-

Other Non Operating Expenses, Total

-3.65

21.22

EBT, Excl. Unusual Items

61.93

147.37

Gain (Loss) On Sale Of Assets

-

1.59

Other Unusual Items, Total

10.17

-14.53

EBT, Incl. Unusual Items

72.1

134.43

EBT, Incl. Unusual Items Growth

+63.65%

+86.44%

EBT, Incl. Unusual Items Margin

6.3

10.21

Income Tax Expense

20.57

37.96

Net Income to Company

51.53

96.47

Minority Interest

0

-0.54

Net Income

51.53

95.93

Net Income Growth

+64.21%

+86.15%

Net Income Margin %

4.5%

7.29%

Preferred Dividend and Other Adjustments

-

-

Net Income to Common Excl. Extra Items

51.53

95.93

Basic EPS - Continuing Operations

4.29

6.91

Basic EPS - Continuing Operations Growth

+64.21%

+60.91%

Diluted EPS - Continuing Operations

4.29

6.91

Diluted EPS - Continuing Operations Growth

+64.21%

+60.91%

Basic Weighted Average Shares Outstanding

12

13.88

Diluted Weighted Average Shares Outstanding

12

13.88

Dividend Per Share

-

0.5

Dividend Per Share Growth

-

-

EBITDA

96.72

169.15

EBITDA Growth

+41.58%

+74.9%

EBITDA Margin %

8.45%

12.85%

EBIT

83.69

156.12

* In Millions of INR (except for per share items)

25,090.95

-159.15

-0.63%

82,149.72

-347.38

-0.42%

51,696.15

-149.05

-0.29%

Nifty 50 Futures

25,294.00

-181.70

-0.71%

5,707.30

+7.4

+0.13%

8,279.41

-3.11

-0.04%

101.637

-0.113

-0.11%